A share price of Sonoma Pharmaceuticals Inc. [SNOA] is currently trading at $0.16, up 6.33%. An important factor to consider is whether the stock is rising or falling in short-term value. The SNOA shares have gain 7.72% over the last week, with a monthly amount glided 1.43%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 9, April 2024, Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States. In a post published today on Yahoo Finance, Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants, today announced the expansion of its Microcyn® Negative-Pressure Wound Therapy (NPWT) Solution products in the United States.
From an analyst’s perspective:
Sonoma Pharmaceuticals Inc. experienced fluctuations in its stock price throughout the past year between $0.12 and $1.52. Sonoma Pharmaceuticals Inc. [NASDAQ: SNOA] shares were valued at $0.16 at the most recent close of the market.
Analyzing the SNOA fundamentals
Trailing Twelve Months sales for Sonoma Pharmaceuticals Inc. [NASDAQ:SNOA] were 12.31M which represents 6.59% growth. Gross Profit Margin for this corporation currently stands at 0.37% with Operating Profit Margin at -0.36%, Pretax Profit Margin comes in at -0.42%, and Net Profit Margin reading is -0.41%. To continue investigating profitability, this company’s Return on Assets is posted at -0.35, Equity is -0.74 and Total Capital is -0.38. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.1466 points at the first support level, and at 0.1370 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.1679, and for the 2nd resistance point, it is at 0.1796.
Sonoma Pharmaceuticals Inc. [SNOA] reported earnings per share of -$0.08 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.21/share, meaning a difference of $0.13 and a surprise factor of 61.90%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were -$0.29 per share as compared to estimates of -$0.24 per share, a difference of -$0.05 representing a surprise of -20.80%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Sonoma Pharmaceuticals Inc. [NASDAQ:SNOA] is 3.98. On the other hand, the Quick Ratio is 3.02, and the Cash Ratio is 0.78. Considering the valuation of this stock, the price to sales ratio is 0.20, the price to book ratio is 0.32.
